정렬된 유전학, Inc.: 손익 계산서 (TTM)

정렬된 유전학, Inc.
KR ˙ KOSDAQ
₩3,400.00 ↓ -110.00 (-3.13%)
2026-06-05
주가
손익 계산서 (TTM)

정렬된 유전학, Inc. 손익 계산서(Income Statement)에는 일정 기간 동안의 소득 및 지출 변화가 표시됩니다. 손익 계산서 데이터에는 판매액(Sales), 매출액(Revenue), 총이익(Gross Profit), 연구개발(R&D), 판매 및 관리비(SG&A: Selling, General and Administrative Expense), 영업이익(Operating Income), 소득세 비용, 이자 비용, 비영업이익, 주당이익(EPS: Earnings per Share) 및 발행 주식수로 구성됩니다.

모든 수치는 지분 단위당 1,000,000 제외의 곱입니다.123456

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
수익 10,059 10,346 11,762 12,942 12,849 13,889 13,753 13,764 14,072 14,209 15,215 14,990 14,933 14,999 15,778 16,509 17,173 17,351 16,016 15,735
변화 (%) 2.86 13.68 10.03 -0.72 8.10 -0.98 0.08 2.24 0.97 7.08 -1.47 -0.39 0.44 5.19 4.64 4.02 1.04 -7.69 -1.75
수익의 % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
매출원가 4,138 4,316 4,424 4,916 4,733 4,690 4,998 4,956 4,866 4,857 4,556 4,250 4,324 4,178 4,629 5,072 5,363 5,382 4,794 4,384
변화 (%) 4.31 2.50 11.12 -3.72 -0.92 6.57 -0.84 -1.82 -0.17 -6.21 -6.72 1.74 -3.37 10.80 9.56 5.73 0.37 -10.92 -8.56
수익의 % 41.14 41.72 37.62 37.99 36.84 33.77 36.34 36.01 34.58 34.19 29.94 28.35 28.95 27.86 29.34 30.72 31.23 31.02 29.94 27.86
총 영업 이익 5,921 6,030 7,338 8,026 8,115 9,200 8,755 8,808 9,206 9,351 10,659 10,741 10,609 10,821 11,148 11,437 11,810 11,969 11,221 11,351
변화 (%) 1.84 21.68 9.38 1.12 13.36 -4.84 0.61 4.52 1.58 13.98 0.77 -1.23 2.00 3.03 2.59 3.26 1.34 -6.24 1.16
수익의 % 58.86 58.28 62.38 62.01 63.16 66.23 63.66 63.99 65.42 65.81 70.06 71.65 71.05 72.14 70.66 69.28 68.77 68.98 70.06 72.14
판매관리비 3,331 3,378 3,794 4,037 4,219 4,444 4,275 4,539 4,796 4,862 5,125 5,104 5,194 5,364 5,616 5,642 5,867 6,154 6,260 6,427
변화 (%) 1.42 12.30 6.40 4.52 5.33 -3.81 6.18 5.67 1.38 5.40 -0.41 1.76 3.29 4.69 0.47 3.97 4.90 1.73 2.67
수익의 % 33.11 32.65 32.26 31.19 32.84 32.00 31.08 32.98 34.09 34.22 33.68 34.05 34.78 35.77 35.59 34.18 34.16 35.47 39.09 40.85
연구개발 861 949 944 877 996 986 1,079 1,327 1,352 1,427 1,684 1,722 2,067 2,373 2,292 2,225 2,378 2,465 2,017 2,285
변화 (%) 10.23 -0.58 -7.02 13.52 -0.95 9.40 22.92 1.91 5.56 18.03 2.21 20.09 14.79 -3.43 -2.90 6.85 3.66 -18.16 13.30
수익의 % 8.56 9.17 8.02 6.78 7.75 7.10 7.85 9.64 9.61 10.04 11.07 11.48 13.85 15.82 14.53 13.48 13.85 14.21 12.59 14.52
운영 비용 8,843 9,146 9,583 10,253 10,362 10,546 10,904 11,346 11,556 11,671 11,878 11,586 12,073 12,387 12,998 13,400 14,060 14,453 13,573 13,593
변화 (%) 3.43 4.78 6.99 1.07 1.77 3.39 4.06 1.85 1.00 1.77 -2.45 4.20 2.60 4.93 3.09 4.93 2.80 -6.09 0.15
수익의 % 87.91 88.40 81.47 79.22 80.65 75.93 79.28 82.43 82.12 82.14 78.07 77.29 80.85 82.59 82.38 81.16 81.87 83.30 84.75 86.39
영업 이익 1,216 1,200 2,179 2,689 2,487 3,343 2,849 2,418 2,516 2,538 3,337 3,404 2,859 2,612 2,780 3,110 3,113 2,898 2,443 2,142
변화 (%) -1.31 81.55 23.42 -7.53 34.45 -14.79 -15.13 4.04 0.87 31.51 2.01 -16.00 -8.66 6.42 11.87 0.12 -6.91 -15.70 -12.33
수익의 % 12.09 11.60 18.53 20.78 19.35 24.07 20.72 17.57 17.88 17.86 21.93 22.71 19.15 17.41 17.62 18.84 18.13 16.70 15.25 13.61
이자 비용 -76 -87 -29 -42 -62 -74 -166 -187 -205 -218 -215 -218 -217 -192 -169 -138 -86 -80 -104 -162
변화 (%) 14.47 -66.75 46.13 46.77 19.35 124.51 12.97 9.17 6.73 -1.63 1.27 -0.34 -11.37 -12.00 -18.19 -37.82 -7.19 30.07 55.48
수익의 % -0.75 -0.84 -0.25 -0.33 -0.48 -0.53 -1.21 -1.36 -1.45 -1.54 -1.41 -1.45 -1.45 -1.28 -1.07 -0.84 -0.50 -0.46 -0.65 -1.03
당기순이익 3,337 3,968 5,542 4,611 4,177 5,346 2,333 2,113 2,188 1,775 3,236 3,442 3,315 2,478 4,128 4,055 3,317 3,743 2,911 2,775
변화 (%) 18.91 39.67 -16.79 -9.42 27.99 -56.36 -9.43 3.55 -18.87 82.32 6.37 -3.69 -25.24 66.57 -1.77 -18.20 12.84 -22.21 -4.69
수익의 % 33.17 38.35 47.12 35.63 32.51 38.49 16.96 15.35 15.55 12.49 21.27 22.96 22.20 16.52 26.16 24.56 19.32 21.57 18.18 17.64

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista